CompletedPhase 2/3

Taurine in Peripartum Cardiomyopathy

Egypt40 participantsStarted 2015-01-01

Plain-language summary

Taurine as an adjunct for early left ventricular recovery in peripartum cardiomyopathy

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Peripartum Cardiomyopathy Exclusion Criteria: * Other identifiable cause for heart failure * low LVEF ≤ 25% * sepsis * autoimmune disease * severe chronic disease * malignancy

What they're measuring

improvement of the left ventricular ejection fraction >10 %

Timeframe: 1 week

Trial details

NCT IDNCT03907267

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-01

View on ClinicalTrials.gov More Peripartum Cardiomyopathy trials